JOB DESCRIPTION
We are seeking a highly motivated early-stage Postdoctoral Researcher to join our research team at the Germans Trias i Pujol Research Institute (IGTP).The successful candidate will join the Resistance, Chemotherapy and Predictive Biomarkers (RCPB) Research Group, led by Dr Eva Martinez-Balibrea from the Catalan Institute of Oncology (ICO) and working within the frameworks of the ProCURE (ICO) and CARE (IGTP) programmes. The group focuses on understanding mechanisms of resistance to cancer therapies (mainly in colorectal cancer) on the identification of predictive biomarkers to improve personalised treatment strategies and on the identification of novel drug targets and therapeutic strategies.The group works in a close collaboration with the Medical Oncology Department of ICO-Badalona, ensuring direct interaction between laboratory research and clinical practice.
WHAT WE OFFER
* Science law Indefinite contract (17/2022) linked to the project.
* Competitive salary, equivalent to a Sara Borrell contract, adjusted according to experience and distributed in 12 payments.
* A highly translational research environment with strong clinical integration
* Estimated starting date: Q2 2026
* Flexible payment (childminding vouchers + restaurant)
* 23 days holiday and 5 days for personal matters + 2 days for Easter + 2 days for Christmas.
* Training capsules by the company.
* Be part of an excellent multidisciplinary research centre with the HRS4R badge.
* Location on the Can Ruti Campus, a major biomedical research hub integrating hospitals, research institutes and core facilities, offers a first-class translational research environment in the Barcelona area in a very stimulating scientific environment.
* The IGTP offers a supportive, friendly and collaborative ecosystem to promote professional development and help you achieve your research goals. The campus is located just 20 minutes from Barcelona, providing easy access to one of Europe’s most vibrant and international cities.
HOW TO APPLY
Interested persons must attach to the application:
* Motivation letter explaining their interest in the position.
* Updated CV.
* Contact of 2-3 references.
* Two representative publications
Applications will be evaluated in accordance with the guiding principles and objectives of the supply systems, following the process described below:
* Curricular evaluation: analysis of the curriculum vitae to assess aspects related to training, professional career and experience in positions related to the job position under selection.
* Personal interview: once the CV has been evaluated, the selected candidates will be called for a personal interview to verify and expand on the information detailed in the résumé and to evaluate aspects related to experience and professional skill.
* *Applications that do not meet the requirements, that are not included in the cases foreseen or that are not processed in accordance with the established procedure will not be considered in the selection process*
QUALIFICATIONS AND EXPERIENCE
Required qualifications
* PhD in a relevant life sciences discipline (e.g. cancer biology, biomedical sciences, molecular biology, immunology, or related fields)
* Proven experience in translational cancer research
* English proficiency at C1 level
* International mobility
* At least two first-author publications in Q1 journals
Key skills and competencies
* Ability to work independently and lead research projects
* Demonstrated capacity to write competitive research proposals
* Strong teamwork and communication skills
Highly desirable experience
* Animal experimentation (in vivo mouse models)
* 3D tumour culture models
* Handling and analysis of omics data
* Background in immunology
MAIN RESPONSIBILITIES
* Co-Leading or leading research projects within the group’s translational research lines
* Supervising and mentoring PhD and master students
* Acting as a scientific reference within the laboratory, contributing to experimental design, troubleshooting and data interpretation
* Preparing research proposals and grant applications, with the support of the group leader
* Contributing to the writing of manuscripts, dissemination of results and participation in scientific meetings
* Actively collaborating with clinicians and other researchers in a multidisciplinary translational environment
FOR MORE INFORMATION
https://www.germanstrias.org/en/research/cancer/13/resistance-chemotherapy-and-predictive-biomarkers-rcpb
DEADLINE FOR APPLICATIONS
The call for applications will close on March 1st 2026
RESOLUCION
#J-18808-Ljbffr